Graft-Versus-Lymphoma Effect Can Be Rapid and Potent in Diffuse Large B-Cell Lymphoma

被引:1
作者
Rashidi, Armin [1 ]
Cashen, Amanda [1 ]
机构
[1] Washington Univ, Sch Med, Div Oncol, Bone Marrow Transplantat & Leukemia Sect, 660 South Euclid Ave,Campus Box 8007, St Louis, MO 63110 USA
关键词
Allogeneic; Graft-versus-host; Transplant; HOST-DISEASE; TRANSPLANTATION;
D O I
10.6002/ect.2016.0074
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
引用
收藏
页码:460 / 462
页数:3
相关论文
共 10 条
[1]   Improved Survival in Lymphoma Patients Receiving Sirolimus for Graft-Versus-Host Disease Prophylaxis After Allogeneic Hematopoietic Stem-Cell Transplantation With Reduced-Intensity Conditioning [J].
Armand, Philippe ;
Gannamaneni, Supriya ;
Kim, Haesook T. ;
Cutler, Corey S. ;
Ho, Vincent T. ;
Koreth, John ;
Alyea, Edwin P. ;
LaCasce, Ann S. ;
Jacobsen, Eric D. ;
Fisher, David C. ;
Brown, Jennifer R. ;
Canellos, George P. ;
Freedman, Arnold S. ;
Soiffer, Robert J. ;
Antin, Joseph H. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (35) :5767-5774
[2]   Clinical evidence of a graft-versus-lymphoma effect against relapsed diffuse large B-cell lymphoma after allogeneic hematopoietic stem-cell transplantation [J].
Bishop, M. R. ;
Dean, R. M. ;
Steinberg, S. M. ;
Odom, J. ;
Pavletic, S. Z. ;
Chow, C. ;
Pittaluga, S. ;
Sportes, C. ;
Hardy, N. M. ;
Gea-Banacloche, J. ;
Kolstad, A. ;
Gress, R. E. ;
Fowler, D. H. .
ANNALS OF ONCOLOGY, 2008, 19 (11) :1935-1940
[3]   The graft-versus-lymphoma effect: clinical review and future opportunities [J].
Butcher, BW ;
Collins, RH .
BONE MARROW TRANSPLANTATION, 2005, 36 (01) :1-17
[4]   Role of donor lymphocyte infusions in relapsed hematological malignancies after stem cell transplantation revisited [J].
Deol, Abhinav ;
Lum, Lawrence G. .
CANCER TREATMENT REVIEWS, 2010, 36 (07) :528-538
[5]   Graft-versus-host disease after donor leukocyte infusions: presentation and management [J].
Frey, Noelle V. ;
Porter, David L. .
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2008, 21 (02) :205-222
[6]   Graft-versus-lymphoma effects: Clinical review, policy proposals, and immunobiology [J].
Grigg, A ;
Ritchie, D .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (09) :579-590
[7]   Phase III Study to Evaluate Temsirolimus Compared With Investigator's Choice Therapy for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma [J].
Hess, Georg ;
Herbrecht, Raoul ;
Romaguera, Jorge ;
Verhoef, Gregor ;
Crump, Michael ;
Gisselbrecht, Christian ;
Laurell, Anna ;
Offner, Fritz ;
Strahs, Andrew ;
Berkenblit, Anna ;
Hanushevsky, Orysia ;
Clancy, Jill ;
Hewes, Becker ;
Moore, Laurence ;
Coiffier, Bertrand .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (23) :3822-3829
[8]   TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donors [J].
Kohrt, Holbrook E. ;
Turnbull, Brit B. ;
Heydari, Kartoosh ;
Shizuru, Judith A. ;
Laport, Ginna G. ;
Miklos, David B. ;
Johnston, Laura J. ;
Arai, Sally ;
Weng, Wen-Kai ;
Hoppe, Richard T. ;
Lavori, Philip W. ;
Blume, Karl G. ;
Negrin, Robert S. ;
Strober, Samuel ;
Lowsky, Robert .
BLOOD, 2009, 114 (05) :1099-1109
[9]   Allogeneic transplantation in lymphoma: current status [J].
Schmitz, Norbert ;
Dreger, Peter ;
Glass, Bertram ;
Sureda, Anna .
HAEMATOLOGICA, 2007, 92 (11) :1533-1548
[10]   A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma [J].
Witzig, T. E. ;
Reeder, C. B. ;
LaPlant, B. R. ;
Gupta, M. ;
Johnston, P. B. ;
Micallef, I. N. ;
Porrata, L. F. ;
Ansell, S. M. ;
Colgan, J. P. ;
Jacobsen, E. D. ;
Ghobrial, I. M. ;
Habermann, T. M. .
LEUKEMIA, 2011, 25 (02) :341-347